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AbstrACt
Objectives Increased test uptake for HIV and viral 
hepatitis is fast becoming a health priority at both 
national and global levels. Late diagnosis of these 
infections remains a critical public health concern in the 
UK. Recommendations have been issued to expand  
blood-borne virus (BBV) testing in alternative settings. 
Emergency departments (EDs) offer a potentially 
important point of testing. This paper presents findings 
from a qualitative study which aimed to explore 
the acceptability and feasibility of a routine opt-out 
combined BBV testing intervention implemented at an 
inner London ED.
Methods We conducted 22 semistructured interviews 
with patients and service providers in the ED over a 
4-month period during the intervention pilot. A grounded 
analytical approach was employed to conduct thematic 
analysis of qualitative study data.
results Core interrelating thematic areas, identified 
and analytically developed in relation to test intervention 
implementation and experience, included the following: 
the remaking of routine test procedure; notions of 
responsibility in relation to status knowledge and test 
engagement; the opportunity and constraints of the ED 
as a site for testing; and the renegotiation of testing 
cultures within and beyond the clinic space.
Conclusion Study findings demonstrate how relational 
and spatial dynamics specific to the ED setting shape 
test meaning and engagement. We found acceptability 
of the test practice was articulated through narratives 
of situated responsibility, with the value of the test 
offset by perceptions of health need and justification 
of the test expense. Participant accounts indicate 
that the nontargeted approach of the test affords a 
productive disruption to ‘at-risk’ identities, yet they 
also reveal limits to the test intervention's ‘normalising’ 
effect. Evaluation of the intervention must attend to the 
situated dynamics of the test practice if opportunities 
of an opt-out BBV test procedure are to be fully 
realised. Findings also highlight the critical need to 
further evaluate post-test intervention practices and 
experiences.
IntrOduCtIOn
Recent years have seen the continuing devel-
opment of more effective and tolerable treat-
ments for viral hepatitis and HIV. Yet, the 
late diagnosis of these infections, associated 
with poorer individual health outcomes and 
increased population transmission, remains 
a prominent health concern at both state1–4 
and global5–8 levels. Delayed access to HIV 
treatment increases the risk of severe health 
complications and premature mortality,9–12 
as well as onward transmission.13–15 Global 
estimates indicate that hepatitis B (HBV) and 
strengths and limitations of this study
 ► Employing qualitative research methods, we draw 
from 22 semistructured interviews to examine the 
acceptability and feasibility of a novel three-com-
bined blood-borne virus (BBV) routine test interven-
tion implemented in an emergency department (ED) 
setting in the UK.
 ► The study offers an enriched understanding of ED 
patient and provider perspectives and experiences 
of the intervention, that may inform and facilitate 
improved implementation of the initiative should the 
pilot be expanded.
 ► A key limitation to the study was interviewing par-
ticipants at point of clinic contact only, and thus not 
being able to explore critical dimensions of the post-
test experience, and more particularly the percep-
tions and experiences of those diagnosed through 
routine ED BBV testing.
 ► We are aware that the small sample size does not 
include individuals who felt themselves to be at risk 
of a positive result, which would likely affect test en-
gagement and intervention experience.
 ► We acknowledge that qualitative data produced 
within and through this particular study context limit 
the generalisability of study findings beyond the pri-
mary setting.
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hepatitis C (HCV) viral infection account for 47% and 
48%, respectively, of the annual 1.4 million deaths from 
hepatitis-related liver cirrhosis and cancer.6 Estimates 
further indicate HBV and HCV diagnosis to be critically 
low at 9% (HBV) and 20% (HCV).7 Care cascade models 
demonstrate that low testing rates are a principal limita-
tion to the ‘success’ of public health targets of treated 
viral hepatitis and HIV viral suppression. With blood-
borne virus (BBV) testing and case diagnosis suboptimal, 
increased test uptake remains a critical national and 
global priority for treatment benefits to be fully real-
ised.6 10 16 
Within the UK, of the estimated 101 200 people living 
with HIV in 2015, as many as 13 500 were unaware of their 
status.17 While the first United Nations Programme on 
HIV/AIDS (UNAIDS) 90-90-90 target (90% of people 
living with HIV being aware of their status) was reached 
in London in 2016, nation-wide figures fell short at 88%.2 
In that year, 42% of HIV diagnoses were made during 
later stages of infection.4 Late diagnosis and low treat-
ment rates for HBV and HCV are reflected in UK hospital 
admissions and mortality from HCV-related end-stage 
liver disease, and HCV or HBV-related liver cancer.3 18 19 
Undiagnosed HCV cases among people who inject drugs, 
the group most at risk of HCV infection in the UK, are 
estimated to be high.20 The British HIV Association and 
National Institute for Health and Care Excellence (2008 
and 2013, respectively) have issued recommendations to 
increase uptake for BBV testing in alternative settings.21 22 
Ongoing efforts to reduce late HIV diagnosis (defined as 
a CD4 count of less than 350 mm),23 alongside shifts in 
policy towards HIV prevention, have sought to expand 
HIV testing initiatives both within and beyond the clinic 
environment.24–29 This has included opt-out testing 
procedures where individuals are informed that a test will 
be conducted unless they indicate they do not want to be 
tested.
Emergency departments (ED) offer a potentially 
important point of testing.30 It has been estimated that 
around one in four of the population in the UK and 
the Republic of Ireland attend EDs in any 1 year.31 For 
individuals not registered with general practitioners 
(GPs), including migrant populations disproportionately 
affected by HIV and chronic HBV and HCV infection,17 32 
EDs can present a primary point of health service contact. 
Routine opt-out testing in the ED setting may also offer 
case finding potential for individuals no longer identified 
as ‘at risk’—such as people who used to inject drugs—
who remain undiagnosed through GP or other health 
service contact until an advanced disease stage.33 34
Much of the global literature on routine HIV testing in 
EDs has emerged from the USA in response to the 2006 
Centre for Disease Control and Prevention guideline 
revisions.35 International evaluation of service provider 
perspectives has identified resource cost and the effi-
cacy of routine test approaches as critical concerns.36–38 
While conscious of the potential public health benefits, 
some view routine HIV testing to sit beyond the remit of 
emergency medical practice.39 40 US-based examinations 
of patient perceptions and experiences have revealed 
levels of confusion around opt-out testing procedures.41 
Yet, studies have also identified an acceptability of 
ED-based routine testing grounded in status curiosity and 
routes of reassurance, alongside the convenience of the 
test opportunity while accessing clinic services.42 43 Patient 
concerns about routine testing procedures have centred 
on issues of confidentiality and the social implications 
of a positive result.42 HIV test practice and engagement 
thus remains both an individually and socially negotiated 
process.44 45
Aspirations that routine BBV testing in more gener-
alised clinic environments could help normalise HIV 
test practices, and lessen illness-related stigma, speak 
to the enduring concern that negative attitudes around 
HIV continue to impede test uptake and diagnosis across 
high-income settings. Despite improved medical realities 
of hepatitis cure,3 and near-normal life expectancy for 
those diagnosed early and able to access HIV treatment,9 
the social meaning of an illness and related test practices 
are less easily reconfigured. Test practices and engage-
ment, situated in sociocultural systems of meaning, may 
also confer risk association.46 Continued misconcep-
tions of hepatitis infection and transmission, alongside 
the stigmatisation of associated 'risk behaviours', nega-
tively impact hepatitis case identification and diagnosis 
across the UK.33 34 47 While shifts in HIV testing norms 
have been witnessed among some communities within 
the UK, perceptions of the social risk attached to both 
test engagement and a potential positive result continue 
to limit test uptake and frequency of testing.44 45 Debate 
concerning the value of nontargeted versus targeted 
test approaches in the HIV field remains ongoing.38 48 49 
Some have argued that targeted HIV testing, centring 
on risk assessment, is necessary in the ED setting to 
ensure that patient interests and ethics of practice are 
protected.49 Others have voiced concerns that continued 
medical segregation and targeted test practices perpet-
uate an HIV exceptionalism, illness stigma and subse-
quent test anxiety.38 39 How test meaning is configured and 
negotiated through a routine practice in the ED setting, 
and the implication for test engagement and uptake, is an 
important dimension of intervention potential.
Critical also to the evaluation of emergent test technol-
ogies across the clinical, community—and more recently 
domestic—spheres, is an understanding of how ‘respon-
sibilisation’ discourses shape health-seeking norms and 
practices. The concept of ‘biological citizenship’, which 
conveys an individualised responsibility to act in keeping 
with both private and collective health,50–52 can be used 
to explore how test technologies and practices function 
as enactments of health citizenship.44 53 The dynamics 
of social, political and biomedical expectation that 
emerge, as novel test technologies are encountered and 
negotiated relative to existing test practices and clinical 
procedures, warrants critical reflection. Attending to the 
‘behavioural domain’ and psychosocial complexity of 
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test practice and engagement, amidst broader ‘normal-
isation’ processes,54 55 remains critical in evaluating the 
efficacy and value of an intervening test technology.
UK-based qualitative research specific to opt-out BBV 
testing in the ED setting remains limited. To our knowl-
edge, there has been no patient-focused analysis of opt-out 
HIV testing in UK EDs to date, nor any qualitative inquiry 
of ED-based routine opt-out testing for HCV and HBV. 
This study aimed to explore the acceptability and feasi-
bility of a combined HIV, HCV and HBV routine opt-out 
testing initiative delivered to adult patients receiving 
routine bloods as part of their emergency care, from the 
perspectives of ED patients and staff. The work offers a 
theoretically driven examination of intervention prac-
tice and experience alongside an applied value to inform 
any potential expansion of the test initiative. The study 
looks at both the immediate responses to the intervention 
components and test event but also at how these experi-
ences are shaped by, and potentially renegotiate, broader 
social norms and forms of test practice and engagement.
MethOds
This paper draws on findings from a pilot qualitative study 
conducted to explore patient and provider responses to 
a combined BBV testing intervention implemented at 
an ED in inner London, UK.56 In all, 22 semistructured 
interviews were conducted with ED patients (n=18) and 
service providers (n=4) between May and August 2016.
Under the BBV test initiative, all ED patients over the 
age of 18 years who have blood samples taken as part of 
their emergency care are routinely tested for HIV, HCV 
and HBV, unless they specifically opt out of the test. Health 
professionals taking the blood sample verbally explain to 
ED attendees that all patients are being routinely tested 
for the three viruses, unless they indicate they do not want 
to be tested. Tests are offered to all adult patients having 
bloods taken, except those individuals who do not have 
the capacity to consent (eg, on account of a psychotic 
illness or cognitive impairment) and those where the test 
offer cannot be verbally communicated and agreed to 
(eg, across language barriers). Where tests are accepted, 
an extra vial of blood is drawn. Information relating to 
the testing intervention was made available through 
leaflets in the department (English language only), with 
posters displayed within ED waiting areas and assessment 
cubicles where bloods are taken. Test results operated on 
a ‘no news is good news’ policy. Those patients returning 
a positive serological result for any of the tested viruses 
were contacted within 14 days and specialist consultation 
arranged.
We sought to recruit both patients and staff participants 
in the ED, so as to explore the multiple dimensions of 
test expectation and experience that frame the interven-
tion. Patient participants were sampled from individuals 
accessing ED services who had bloods taken as part of 
their emergency care and included individuals who were 
offered and accepted the BBV test (n=10); individuals 
offered the test but who opted out (n=1) and individ-
uals who did not recall being offered the intervention, 
assumed not tested (n=7). Insofar as was possible, we 
sought to include patients across a range of ages, genders 
and ethnic backgrounds to capture the diversity of the ED 
population. We interviewed nine female and nine male 
patients in the ED, between 23 and 82 years in age, of 
varying ethnicities (see table 1 for information relating 
to patient participants). Patient and staff participants 
were recruited across different times of the day/evening, 
both during the week and at weekends to reflect varia-
tions in patient populations and department workloads. 
Health professionals were sampled from staff members 
directly involved in taking bloods and implementing 
the test intervention. Staff participants included women 
and men of different staff grades, who had worked at the 
department for between 3 and 8 years.
Interview discussions were semistructured, shaped by 
a topic guide developed by the research team but also 
guided by participants’ responses. Interviews commenced 
after participants gave written informed consent and, with 
their permission, were audio-recorded. While interpreta-
tion services had been identified if required, all interviews 
were conducted in English. Data were collected by LC 
who was not known to participants prior to the study, with 
all interviews conducted on the ED site. Interviews lasted 
between 20 and 50 minutes, as determined by patient and 
staff availability. Interviews were immediately stopped in 
the event of the patient receiving further medical care. 
While interviews were resumed wherever possible, in 
cases where patient participants were transferred to other 
hospital departments or discharged, interviews could not 
always be concluded. Interview participants were asked 
about their views and (where applicable) direct experi-
ences of the test intervention; previous test experiences 
and current test practices; knowledge and awareness of 
HIV, HCV and HBV viruses, transmission risks and treat-
ments; felt and perceived barriers and facilitators to BBV 
testing; and the felt appropriateness of the ED as a site 
for testing.
All interview data were transcribed verbatim, with 
personal identifying details removed. In keeping with 
a grounded analytical approach to inform thematic 
development,57 58 preliminary data coding and analysis 
commenced early in data collection, informing later 
interviews and allowing for emerging themes to be further 
explored across patient and staff accounts. Initial coding 
examined both a priori interests as well as inductive codes 
grounded in the study data. Secondary-level thematic 
coding was later conducted across the full dataset to 
further fracture the data and allow for the development 
of conceptually driven categories, drawing on relevant 
theoretical literature, particularly in relation to respon-
sibilisation and biological/health citizenship.50–53 Points 
of tension and convergence in relation to emerging 
thematic areas were explored both between patient 
accounts and across patient and provider responses. Core 
thematic areas that emerged included the following: the 
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renegotiating of routine procedure; felt and perceived 
testing responsibilities; the opportunity and limitations of 
the ED as a site for testing; and the interplay of testing 
cultures within and beyond the clinic. All names used in 
the analysis are pseudonyms.
This study was undertaken as part of the National Insti-
tute for Health Research Health Protection Research 
Unit in Blood Borne and Sexually Transmitted Infections 
at University College London in partnership with Public 
Health England and in collaboration with the London 
School of Hygiene and Tropical Medicine.
Patient and Public Involvement: Pre-study consultations 
were conducted with community organisation repre-
sentatives working in the HIV, HCV and HBV fields to 
inform the design of the study. Patients in the ED were 
not involved in the study design phase of the research. 
All study outputs and publications will be disseminated to 
those study participants who opted to give contact details 
for this purpose.
results
Our study findings report on the perceptions and experi-
ences of ED patients and service providers in response to 
the implementation of a routine BBV test intervention in 
a UK ED setting. While not all patient participants were 
offered the intervention, in being eligible for interven-
tion practice they contributed valuable insight into the 
acceptability, feasibility and limitations of the ED as a site 
for routine BBV testing. Our analysis explores the inter-
vention’s potential and practical negotiation through 
four interrelating thematic areas: the remaking of routine 
test procedure; notions of responsibility in relation to 
status knowledge and test engagement; the opportunity 
and constraints of the ED as a site for testing; and the 
renegotiation of testing cultures within and beyond the 
space of the clinic.
A remaking of routine
Processes of integrating an additional test into standard 
ED practice were shaped by staff and patient interactions 
with, and responses to, the various intervention compo-
nents. A number of patient participants described them-
selves as having been too preoccupied and distracted to 
register the intervention posters—a ‘background’ not 
properly taken in. Staff, in contrast, depicted the posters 
as an aid to intervention procedure; a visual reminder 
and point of reference in the assessment cubicle where 
blood samples are taken. Both patient and staff partici-
pants stressed the importance of how the verbal explana-
tion was delivered; ‘the way you say it’, keeping it simple. 
Patient accounts make positive reference to the ‘straight-
forward’, ‘low-key’, ‘casual’ and nonintrusive communica-
tion that presented the test as just another part of routine 
procedure; no fuss:
The guy yesterday when he took it, he was so laid back 
about the one sentence that he made, that you almost 
Table 1 Patient participant information
Pseudonym Gender Age (years) Region of origin BBV test intervention response
Ryan Male 18–29 North America BBV test offer declined
Sofiya Female 30–49 East Europe BBV test offer not recalled, assumed not tested
Carlotta Female 18–29 West Europe (excluding the UK) BBV test offer accepted 
Malcom Male 30–49 UK BBV test offer not recalled, assumed not tested
Karen Female (30–49*) UK BBV test offer accepted
Ramisa Female (30–49*) South Asia BBV test offer accepted
Phil Male 30–49 UK BBV test offer accepted
Ehsan Male (50+*) Middle East BBV test offer not recalled, assumed not tested
Sten Male 30–49 West Europe BBV test offer not recalled, assumed not tested
Dennis Male 50+ UK BBV test offer accepted
Hana Female 18–29 South Europe BBV test offer not recalled, assumed not tested
Julia Female (18–29*) West Europe BBV test offer not recalled, assumed not tested
Matas Male 30–49 East Europe BBV test offer not recalled, assumed not tested
Dan Male 30–49 UK BBV test offer accepted
Imogen Female 50+ UK BBV test offer accepted
Ishani Female 30–49 UK BBV test offer accepted
Lena Female 18–29 East Europe BBV test offer accepted
Khaled Male (30–49*) Middle East BBV test offer not recalled, assumed not tested
*A number of patient interviews were interrupted due to patient care pathways. In cases where interviews were not able to be resumed (eg, 
where patients were transferred/discharged), patient information has insofar as is possible been extracted from interview data. Where patient 
ages were not available, an age-range estimate has been given based on biographical information given by patients during the interview.
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didn’t want to say no. It wasn’t a big deal, do you see 
what I mean? Like, there was no negativity attached 
to the way he was talking. (Ishani)
Adapting the test procedure to the demands of an ED 
workflow appears to support a more neutral and acces-
sible practice, where the less of the event helps bypass 
the potential ‘negativity’ of the test idea. Staff indicated 
that the presence of friends and relatives during blood 
procedures was common, but that communication 
surrounding the test did not typically sit apart from 
‘normal history taking’ and the established confidenti-
ality of the room. While the intervention would at times 
be conducted in the presence of others, it was avoided in 
situations where those others were translating. The ‘no 
news is good news’ results system, while not infringing on 
patient decisions to test, was seen as less acceptable. The 
majority of patient participants indicated a preference to 
receive the test result, aware that ‘mistakes happen’. The 
‘no news’ window could potentially be anxiety provoking, 
particularly if status was a point of concern—a ‘what if’ 
that would benefit from a more definite confirmation: ‘it 
would be nice to know so, you know’ (Phil).
For some ED staff, the extra vial has, over time, become 
habit. Increasingly ‘more of a reflex action’, the test offer 
was less something remembered or forgotten but rather 
just done, affording staff the opportunity to see how 
the test practice both could and does fit with existing 
procedures:
I think it’s just, kind of like, there was an, ‘Oh, for 
goodness sake, yet another thing for us to do in our 
assessment cubicle,’ and then actually like, ‘Oh, no, 
this is, this is easy, this is not a problem’. (Clinic staff)
Yet, complex clinic situations can render the interven-
tion procedure more difficult to navigate. Ascertaining 
the extent to which the test had been effectively commu-
nicated across language barriers was a widely discussed 
concern. Staff also spoke of the difficulties of assessing 
capacity to consent for patients in more critical health 
conditions and particularly under the pressure of meeting 
immediate treatment demands:
It [conducting intervention] just depends on the 
sickness, I guess, how sick the patient is and how fo-
cused you are at trying to get all the treatment for 
the patient right in, done, and gauging are they ac-
tually understanding what you’re saying at this point. 
(Clinic staff)
Staff accounts indicated that efforts to integrate the test 
into routine practice would often require a judgement 
call—individual assessments on whether or not the inter-
vention should be offered, and then how well it had been 
understood and consented to. Ambiguities of interven-
tion procedure exposed through complex, pressurised 
clinic situations—for example, whether to take blood 
samples from trauma patients in critical conditions and 
the extent to which other family members may become 
involved in this process—can give rise to divergent test 
practices with broader ethical implications, where the 
appropriateness of the test offer and delivery, and crit-
ically processes of patient consent, may become less 
apparent and acceptable to both staff and patients. Inter-
vention implementation also meets ongoing resistance in 
the ED ‘working environment’, with high patient volume, 
intense workloads and rapid staff turnover impeding 
attempts to ‘remember’ the still ‘extra’ blood vial. The 
volume of patients that underscores both the opportu-
nity and advantage of ED-based testing is the same 'mass 
volume' that makes an altered routine more difficult to 
establish. In the context of a department ‘struggling to 
do the basic things’ while attending large numbers of 
acutely ill patients, the extra vial is still felt to be an ‘extra 
element’ (clinic staff).
A responsibility to know
A prominent feature of participant accounts was the 
view that 'it's better to know'. Described as a ‘good’ and 
‘important’ thing to do, patient accounts indicate a 
generalised expectation not only to test but also to want 
to test—a route to ‘feel[ing] healthier’ and ‘clean’:
If these things are curable, then fine, they’ve heard 
something that they need to know. If they’re not, 
then it gives them time to get themselves in order. I 
think it’s always better to know than not know. Do I 
believe that? Yes, I do, yeah. (Imogen)
Expectations to test are further reinforced when treat-
ment is known to be available. For Ehsan, the 'treatability' 
of HIV renders the phobia of testing less legitimate, a fear 
that should not still be there. Matas’ deferral of interferon 
treatment when diagnosed with hepatitis C 4 years previ-
ously, waiting to see if ‘science comes up with anything 
better’ contends the assumed linearity of a ‘test and treat’ 
ethic. Yet, managing the knowledge of a health condition 
was implied by Matas and others as something that just 
has to be done; ‘a bit unexpected but you know what can 
you do? It is like it is’ (Matas); ‘… it’s not going to be easy 
to take, you know, but that’s, that’s life’ (Malcom).
Patient participants also voiced a public responsibility 
to know. This was positioned in relation to population 
health—to ensure against onward transmission—but 
also direct to the state. For Imogen, expectations of state 
support are reciprocated in expectations of individual 
health monitoring and management:
We’re adults, we’re responsible for our actions […] 
we need to check these things […] that’s, kind of, 
part of my psyche, you look after yourself and you 
do not expect the health service to look after you. 
Well, you do, but you have to have played your part. 
(Imogen)
Engaging with the ‘free opportunity’ of the test is 
implied to constitute an act of health citizenship; a 
demonstration of meeting expectations, being respon-
sible, playing one’s part. For the majority of participants, 
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the right of the patient to choose was critical. Yet, a small 
number felt the test should be ‘obligatory’. Insofar as 
infection poses a risk beyond the individual, the 'safe-
guard' of the test should be engaged with ‘for the good 
of society’ (Ehsan). For Ehsan, the right to choose is a 
privilege of 'out there' that changes when you enter the 
‘here’ of the ED clinic space. The act of accessing the 
service denotes a responsibility to the clinic network—the 
people, place and resources that you have sought help 
from—that forgoes the right to decline.
All patient participants, irrespective of whether the 
test had been offered, indicated confidence in a nega-
tive result. Those who accepted the test engaged with the 
practice either as a form of opportunistic assurance—a 
‘might as well’—or indifference—‘I’m not concerned 
about any of those things’. Tests actively sought in the 
past were linked either to changes in relationship status 
or increased sense of risk. While participants indicated 
they would initiate a test if they felt cause to do so, few 
said it would be something they would consider other-
wise. Without an explicit need, test engagement remains 
predominantly passive; ‘it’s on my to do list’—thought 
about, but not a priority. In the absence of status anxiety, 
acceding to new routine procedures is easily done. How 
the test offer and practice would be received by those who 
feel more at risk is less apparent. A potential reluctance to 
test was speculated in ‘others’ who might be more anxious 
about a positive result: ‘the thought of having something 
wrong with you, some people would rather not know’ 
(Karen). Felt responsibilities to know therefore sit rela-
tive to an anticipated reality of knowing, and the irrevers-
ible knowledge process enacted through the test event; 
'once you know that's it, you know, you’ve got it' (Dan).
A time and place
The appropriateness of the ED as a site for testing was 
questioned by a small number of patient participants. 
Ryan, though supportive of the offer, did not feel he 
had the mental capacity for it that day: ‘I don’t really 
want to pile on the bad news […] I don’t want a double-
whammy—that would be an unpleasant day’ (Ryan). For 
Khaled, the test conflicts with the principal tenet of the 
'emergency' remit:
Emergency services is always full with emergencies so 
they have to deal with priorities […] But that one is 
not that kind of priority because if you have it you 
have it, you cannot cure it by emergency services, you 
have to take a long term treatment. (Khaled)
Unless directly ‘applicable’ to a patient’s differential 
diagnosis, the test should be conducted at some other 
time and some other place; 'emergency is for emergency' 
(Khaled). In tension with the overriding acceptability of 
the intervention was the less articulated counter narrative 
of this isn't the time.
Yet, the more dominant narrative was one of an 
 opportunity presented. Participants who accepted the 
intervention commonly constructed the test offer as a 
well-situated add-on, 'they're taking bloods anyway'. The 
ease and convenience of an extra vial were thought to 
encourage people to test who otherwise would not have 
sought to do so:
A person won’t just go out there to have a HIV test, like 
on an ordinary day, they wouldn’t even think about it 
[…] just imagine you spend your day and would I just 
go, ‘I’m going to go and have a HIV test today,’ they 
wouldn’t […] because you think, ‘Oh, I haven’t got 
it, you know, I don’t need to,’ you wouldn’t do it in a 
million years. (Ramisa)
Despite taking time to integrate into pre-established 
blood routines, staff indicated that the drawing of another 
vial from someone already having bloods taken was both 
minimal but also practical: ‘we are already putting a 
needle into somebody’s vein, we are already taking blood’ 
(clinic staff). The ED site offers a point of contact with 
individuals who, in the absence of felt risk, are neither 
testing nor thinking about testing. Opportunities of 
re-contact also present with individuals who have—as in 
the case of Matas—disengaged from care services. Unreg-
istered with a GP, Matas has had minimal service contact 
beyond intermittent visits to emergency care, remaining 
unaware of recent advances in HCV treatment options.
The ED setting also offers an alternative point of contact 
for HIV testing with individuals less able, or willing, to 
access sexual health services. For some participants, the 
anonymity of a sexual health clinic afforded a heightened 
sense of privacy—‘there are no questions, no nothing’ 
(Sten). For others, the visibility of the sexual health clinic 
presented complications, with service access potentially 
compromised in light of what being seen in the clinic 
might imply:
I will take an example of Muslim people like me. You 
will see loads of girls wearing scarf but doing things 
that you’re not supposed to do, then in the end case 
she thinks she has something, how she will go to sex-
ual health clinic? Just example of people who are like 
me. (Hana)
For Ehsan, the sexual health clinic constitutes a space of 
heightened anxiety and concern; a difficult space to enter 
that concedes both to the self and others not only that 
there is a problem but also that it is this type of problem:
If you enter that building I think it’s this […] Not 
phobia, it’s […] it’s that there is something seriously 
wrong with you […] it takes you to totally different 
atmosphere and you can feel it when you see people 
sitting down […] there is a stigma attached to that 
building. (Ehsan)
In contrast to the known specificity of the sexual health 
clinic, Ehsan positions the ED setting as a place where 
you do not feel that difference, there are 'too many 
different types of illnesses’. The ED supports a protective 
anonymity and neutrality of space; accessed by all, where 
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everyone has something going on but no one knows what 
exactly.
Cultivating a 'culture of testing’
Processes of test implementation simultaneously enable 
and demand a renegotiated ‘culture of testing’ within 
the ED setting. Intervention efforts point towards a stan-
dardising of staff practice and patient expectation—one 
that would see ‘testing everyone’, and thus getting tested, 
made the norm. The test-all precedent was seen to alle-
viate the sense of an implied, or felt, target:
… and the fact that it's on the wall and it's saying that 
it's a, you know, 'we're asking everybody if you want 
to be tested' then it's kind of 'oh OK, you know, you 
probably asked the guy that was in before, I'm no dif-
ferent'. (Phil)
Helping dispel initial anxieties of why are you testing me?, 
the routinising of the test practice was seen to improve 
the test experience. The test ‘standard’, easier to deliver 
and more readily received, contrasts with a differential 
test that ‘puts the fear of god into that one person, that 
we’re testing you for it’ (clinic staff). Staff participants’ 
reflections on the intervention in practice suggest that a 
standardised test approach both facilitates greater diag-
nostic opportunity and helps diffuse prevailing precon-
ceptions of those ‘affected’, within and beyond the clinic 
environment.
I think we’re missing out on a massive group of peo-
ple by, by targeting it and I think here we’re kind 
of getting people from every spectrum, every walk 
of life and […] there are people who are having 
positive results that you kind of don’t, […] it’s not 
someone that, and this is going to sound awful but 
it’s not someone that you expect to have had a posi-
tive test. I think there’s still, even for us [clinic staff] 
there’s still kind of like a little bit of stigma around it 
and you attach it to certain groups of people. (clinic 
staff)
As patients’ accounts reiterated, public misconceptions 
relating to HIV—though ‘changing’—were still felt to be 
present and problematic.
Yet, perceptions of test value and expectation are also 
shaped by how legitimate patients considered their (and 
others’) claims to clinic time and resources. The efficacy 
of the intervention—how efficient it is and who is going 
to pay—was a question often posited by patient partici-
pants: ‘if the benefits of doing it cannot be justified by 
the resource cost that would be needed to do it then 
clearly it can’t be done […] It’s a no-brainer’ (Malcom). 
Patient anxieties of ‘wasting time’ betray a reluctance to 
access primary care until a specific health need can be 
clearly evidenced. Efforts to reconfigure testing norms 
and expectations can thus sit in tension with perceptions 
of systemic constraints that do not encourage or support 
people to ‘just check’:
It has to be like a society, society’s mentality to just 
check, you know take care of your body and, you 
know, make sure everything is okay and not only 
when you’re, you know, dying, or something is seri-
ously wrong because many times it’s too late when 
that happens, you know. (Lena)
Current testing cultures orientate around having 
reason, legitimised through an identifiable symptom or 
risk. Efforts to routinise the test practice remain situated 
within, and shaped by, broader norms of service deferral; 
an ethic of waiting until need is established, where public 
responsibilities to monitor one’s health sit relative to the 
cost of doing so.
Renegotiating testing cultures meets further resistance 
in the limited knowledge and talk of the tested viruses. 
Although they did not infringe on participants’ decisions 
to test in this study, illness stigma and related anxieties 
were commonly offered as a reason why 'others' may 
prove reluctant. Interview discussions orientated heavily 
around HIV, with HBV and HCV both less understood 
and spoken about. While degrees of HIV talk differed in 
relation to cultural norms and across generations, there 
was consensus that conversations would only ever go so 
far. Critical boundaries were identified between talking 
about HIV and having HIV: ‘people talk about it (HIV) just 
as a, distant thing’ (Lena). The condition was predomi-
nantly depicted as an abstraction, experienced remotely 
through news and media coverage. Rarely discussed in 
the private sphere, limits to knowledge were accounted 
for in not needing to know:
To be honest, the truth is I feel like it’s something 
that doesn’t affect or concern me. I know that sounds 
ignorant and stupid, but I’m just being honest with 
you […] And I think that’s how a lot of people feel. 
(Ishani)
Both staff and patient responses highlight the need for 
concurrent change in public norms, perceptions and talk 
surrounding HIV and hepatitis beyond the intervention, 
if routine opt-out BBV testing is to be understood and 
accepted, and a broader culture of testing supported.
dIsCussIOn
Our findings indicate that routine opt-out BBV testing 
in the ED setting is viewed as an acceptable and valuable 
practice by the majority of patient and staff participants. 
Consistent with qualitative findings exploring HIV testing 
acceptance in EDs in the USA, participants’ receptivity 
to testing pivots around the narrative that it’s better to 
know43—a ‘better’ widely underscored by the perceived 
availability and efficacy of HIV treatment. Knowledge of 
hepatitis viruses and respective treatments was notably 
limited. Problems of test implementation were primarily 
linked to broader systemic constraints,38 where unre-
lenting pressures of the ED working environment 
impeded the process of integrating the test into routine 
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practice. Service providers spoke of the difficulties of 
navigating the change of the intervention, rather than 
reservations around the intervention itself. Yet, clinic staff 
also anticipated that once embedded into department 
procedure, and in time patients’ expectations, the feasi-
bility of the intervention would align more closely with 
the observed acceptability of the test practice.
narratives of responsibility
Findings suggest that the acceptability of the inter-
vention is shaped in part by negotiations of competing 
responsibilities. A dominant narrative across participant 
responses was the responsibility to know. Responsibilities 
of knowing were articulated in relation to a private well-
being of the individual but also a public responsibility—
to know your status, more specifically a positive status, 
to ensure against onward transmission. Resonating with 
broader neoliberal discourses of citizen expectation 
and biological responsibility, participant accounts would 
often position test uptake as an enactment of health 
citizenship—the perceived role of a patient–citizen.50 51 
Yet, narratives of responsibility were at once countered 
by an absence of need and the positioning of the self as 
not 'affected'. Patient participants’ test histories demon-
strate, for the most part, norms of passive test engage-
ment made active in response to an altered sense of risk. 
Transitions from an assumed negative to a potential posi-
tive—where felt expectations to know converged with an 
overt health need—occasioned a more proactive, albeit 
temporary, test engagement. Expectations of having need 
that underscore participant narratives work to ensure the 
legitimacy of the test claim on clinic time and resources. 
With patients’ heightened awareness of service rationing, 
a questioned appropriateness pulls against the dominant 
script of intervention acceptability. Responsibilities of 
knowing thus sit in tension with perceived personal and 
state responsibilities to ensure that increasingly limited 
clinic resources are efficiently deployed. This likewise 
speaks to a situated ethics of a test-for-all approach,39 
wherein the value of the test is positioned relative to 
the cost of its delivery and anticipated rate of return. In 
the absence of explicit risk and subsequent need, the 
test expense is less clearly supportable.
A productive disruption
The extent to which the test practice can be made routine 
and move beyond the initial disruption of its implemen-
tation—the point at which the extra vial ceases to be an 
'extra'—though envisioned, remains uncertain. While 
staff spoke of the test practice becoming more instinc-
tive over time, the 'struggle' to make the intervention a 
routine procedure remains evident. Amidst the pressures 
of ED workflows, the intervention still posits a point of 
disruption. Yet, efforts to standardise the test practice also 
allow for a more productive disturbance. First, the inter-
vention has neutralising potential as test practice and 
meaning are reconstituted within and through the partic-
ularities of the emergency clinic environment.59 The 
‘struggle’ to integrate the test into department procedure 
amidst uncompromising clinic demands enables, necessi-
tates and makes visible the ‘standardisation’ of test prac-
tice; the test is rendered less of an event because it has to 
be. The high patient traffic, close proximity and discern-
ible number of others tested make the routine of the 
procedure more evident. Second, the tentative displace-
ment of the test target in a generalised clinic environment 
disrupts ‘at-risk’ boundaries felt to be conferred through 
targeted test practices and engagement. The routine 
practice of the test points to a test need, expectation and 
responsibility that extends beyond existing risk parame-
ters. This suggests a potential of the spatial dynamics of 
the ED setting to challenge socially embedded risk asso-
ciations. Obscuring ‘affected/unaffected’ binaries stands 
to lessen the social risk of being seen to be tested. The 
routine of the procedure thus affords a form of public 
protection that, in turn, lends the intervention a social 
value beyond the quantifiable efficacy of intervention 
uptake and diagnostic case return.
situated intervention potential
Yet, our study findings also call attention to the limits of 
the test intervention’s ‘normalising’ effect. The extent 
to which risk associations of testing technologies can be 
reconfigured through generalised test settings and proce-
dures remains questionable. As demonstrated in our find-
ings, while the nontarget approach was positively received 
among study participants, test uptake was framed by 
narratives of test ambivalence. Distinctions between those 
who were and were not ‘at risk’, though momentarily 
disrupted, were then refashioned through retrospective 
accounts of test engagement (or would-be engagement) 
that continued to position the self as one not affected. 
Such narrative devices, though peripheral, call atten-
tion to embedded social constraints that continue to 
impede patients’ efforts to renegotiate tacit risk identi-
ties conferred through test practices and engagement. 
Expectations that a standardisation of clinic practice 
could translate into a ‘normalisation’ of test experience 
is a formidable aspiration, but one that faces resistance 
and local negotiation. As we have observed, the routin-
ising of the test procedure at once shapes and is shaped 
by: prior knowledge and experience of the viruses to be 
tested; the dynamics of the clinic space and therapeutic 
pathways; perceived health responsibilities; socially 
embedded test associations and the anticipated reading 
of test engagement by others. Our findings indicate 
that the intervention’s embryonic effect is constituted 
through, and contingent on, the processes of its local 
implementation.59 60 Test meaning and value are recur-
sively produced, as altered norms of practice are variously 
encountered and negotiated within and beyond the test 
event.
Policy implications and study limitations
Our qualitative analysis offers a critical sociological 
contribution to intervention evaluation that will enrich 
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statistical appraisal of BBV test uptake, diagnosis rates 
and cost-effectiveness.56 An improved understanding of 
participant perspectives and intervention experience, as 
supported by this study’s analysis, will likely contribute to 
the success and efficacy of intervention scale-up beyond 
the pilot. Study findings highlight the need to attend 
to the local particularities of intervention implemen-
tation if the benefits of the test initiative are to be fully 
realised. Considerations of expanded practice in the UK 
must take seriously the intensity of ED workflows and 
the implications of increasing demands on already over-
stretched emergency care resources. Intervention reach 
and test uptake among migrant populations—as perti-
nent to those disproportionately affected by HIV and viral 
hepatitis in the UK2 3 32 47—will likely remain restricted 
while language barriers continue to preclude test offer 
and delivery to this patient subgroup. Yet, our findings 
also demonstrate the intervention’s potential to extend 
an alternative route of contact with individuals at risk of 
falling through the gaps,33 or positioned beyond targeted 
test strategies. Significant also is the extent to which HBV 
and HCV, relative to HIV, were not only less discussed but, 
for the most part, much less understood. Limited public 
knowledge of these conditions calls to question the ethical 
implications of introducing an opt-out test procedure 
among individuals who have little if any understanding of 
what a positive result might mean.
Interpretation of our qualitative findings must also 
attend to a number of study limitations. First, study find-
ings draw from a small, site-specific population. Second, 
our sample does not include patients who felt themselves 
to be potentially at risk of a positive result. As identi-
fied through explorative research of alternative HIV 
test interventions,44 test practices and the acceptability of 
intervention procedure will invariably take on different 
meanings for those negotiating a potential positive, 
and demands further enquiry. Likewise, in interviewing 
individuals at the point of clinic contact, the study was 
not able to explore the views and experiences of those 
diagnosed through the ED test procedure, and thus the 
onward dimensions of the test intervention that are inte-
gral to the intervention process. Exploration of post-test 
experience, and its implications for test acceptability and 
engagement, is needed for a more comprehensive under-
standing and evaluation of intervention experience and 
value.
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